Lactobacillus rhamnosus LC705 Together with Propionibacterium freudenreichii ssp shermanii JS Administered in Capsules Is Ineffective in Lowering Serum Lipids

Journal of the American College of Nutrition

Volumn 27, Issue 4, 2008, Pages 441-447

  Hatakka, Katja ^a,c   Saxelin, Maija ^a   Mutanen, Marja ^b   Korpela, Riitta ^b,c,d   Holma, Reetta ^c  

^a Department of Applied Chemistry and Microbiology ^*  (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c VALIO LTD   (Finland)

^d FOUNDATION FOR NUTRITION RESEARCH   (Finland)

Author keywords

Capsule; Crossover study; Lactobacillus rhamnosus LC705; Propionibacterium freudenreichii ssp shermanii JS; Serum lipids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BACTERIAL STRAIN; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFECT; HABIT; HUMAN; HYPERCHOLESTEROLEMIA; INTERVENTION STUDY; LACTOBACILLUS RHAMNOSUS; LIFESTYLE; LIPID BLOOD LEVEL; MALE; MONITORING; NUTRIENT; PROPIONIBACTERIUM FREUDENREICHII SHERMANII; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROPIONIBACTERIUM;

LACTOBACILLUS RHAMNOSUS; PROPIONIBACTERIUM FREUDENREICHII;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FECES; HUMANS; HYPERCHOLESTEROLEMIA; LACTOBACILLUS RHAMNOSUS; LIPIDS; MALE; MIDDLE AGED; PROBIOTICS; PROPIONIBACTERIUM; YOUNG ADULT;

EID: 58749100326     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2008.10719723     Document Type: Article

References (43)

1. Montrose DC, Floch MH: Probiotics used in human studies. J Clin Gastroenterol 39: 469-484, 2005.
2. O'Sullivan MG, Thornton G, O'Sullivan GC, Collins JK: Probiotic bacteria: myth or reality? Trends Food Sci Technol 3: 309-314, 1992.
3. Mann GV, Spoerry A: Studies of a surfactant and cholesteremia in the Maasai. Am J Clin Nutr 27: 464-469, 1974.
4. Pereira DIA, Gibson GR: Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37: 259-281, 2002.
5. Somkuti GA, Johnson TL: Cholesterol uptake by Propionibacterium freudenreichii. Curr Microbiol 20: 305-309, 1990.
6. Pereira DIA, Gibson GR: Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68: 4689-4693, 2002.
7. Liong MT, Shah NP: Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci 88: 55-66, 2005.
8. du Toit M, Franz CMAP, Dicks LMT, Schillinger U, Haberer P, Warlies B, Ahrens F, Holzapfel WH: Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Intern J Food Microbiol 40: 93-104, 1998.
9. Pereira DIA, McCartney AL, Gibson GR: An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol 69: 4743-4752, 2003.
10. Ridlon JM, Kang D-J, Hylemon PB: Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47: 241-259, 2006.
11. Broccali G, Berti M, Pistolesi E, Cestaro B: Study of the effect of lactobacillus GG supplementation in combination with and without arginine aspartate on lipoproteins and liver peroxidation in cholesterol-fed rats. Intern J Food Sci Nutr 51: 475-482, 2000.
12. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, Iwatsuki K, Kokubo S, Hosono A: Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86: 2452-2461, 2003.
13. Chiu C-H, Lu T-Y, Tseng Y-Y, Pan T-M: The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet. Appl Microbiol Biotechnol 71: 238-245, 2006.
14. St-Onge M-P, Farnworth ER, Jones PJH: Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am J Clin Nutr 71: 674-681, 2000.
15. Hepner G, Fried R, St Jeor S, Fusetti L, Morin R: Hypocholesterolemic effect of yogurt and milk. Am J Clin Nutr 32: 19-24, 1979.
16. Agerbæk M, Gerdes LU, Richelsen B: Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 49: 346-352, 1995.
17. Richelsen B, Kristensen K, Pedersen SB: Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins-a placebo-controlled and double blind study. Eur J Clin Nutr 50: 811-815, 1996.
18. Bukowska H, Pieczul-Mróz J, Jastrzebska M, Chelstowski, Naruszewicz M: Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 137: 437-438, 1998.
19. Schaafsma G, Meuling WJA, van Dokkum W, Bouley C: Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr 52: 436-440, 1998.
20. Bertolami MC, Faludi AA, Batlouni M: Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 53: 97-101, 1999.
21. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A: Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 54: 288-297, 2000.
22. Massey LK: Effect of changing milk and yogurt consumption on human nutrient intake and serum lipoproteins. J Dairy Sci 67: 255-262, 1984.
23. Andersson H, Bosaeus I, Ellegård L, Grahn E, Tidehag P, Hallmans G, Holm S, Sandberg AS: Effects of low-fat milk and fermented low-fat milk on cholesterol absorption and excretion in ileostomy subjects. Eur J Clin Nutr 49: 274-281, 1995.
24. de Roos NM, Schouten G, Katan MB: Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthymen and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr 53: 277-280, 1999.
25. Naruszewicz M, Johansson M-L, Zapolska-Downar D, Bukowska H: Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 76: 1249-1255, 2002.
26. Fabian E, Elmadfa I: Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann Nutr Metab 50: 387-393, 2006.
27. Kiessling G, Schneider J, Jahreis G: Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 56: 843-849, 2002.
28. Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A: The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr 54: 856-860, 2000.
29. Vaskonen T: Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem 14: 492-506, 2003.
30. Myllyluoma E, Kajander K, Mikkola H, Kyrönpalo S, Rasmussen M, Kankuri E, Sipponen P, Vapaatalo H, Korpela R: Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection. Dig Liver Dis 39: 516-523, 2007.
31. Suomalainen T, Sigvart-Mattila P, Mättö J, Tynkkynen S: In vitro and in vivo gastrointestinal survival, antibiotic susceptibility and genetic identification of Propionibacterium freudenreichii ssp. shermanii JS. Int Dairy J 18: 271-278, 2008.
32. Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT, Wright PFA: Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin Diag Lab Immunol 6: 799-802, 1999.
33. Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT, Wright PFA: The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol 26: 131-135, 1999.
34. Gratz S, Mykkänen H, El-Nezami H: Aflatoxin B1 binding by a mixture of Lactobacillus and Propionibacterium: in vitro versus ex vivo. J Food Protect 68: 2470-2474, 2005.
35. Ouwehand AC, Langström H, Suomalainen T, Salminen S: Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 46: 159-162, 2002.
36. El-Nezami HS, Polychronaki NN, Ma J, Zhu H, Ling W, Salminen EK, Juvonen RO, Salminen SJ, Poussa T, Mykkänen HM: Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr 83: 1199-1203, 2006.
37. Friedewald WT, Levy RJ, Frederickson DS: Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 18: 499-509, 1972.
38. Tynkkynen S, Satokari R, Saarela M, Mattila-Sandholm T, Saxelin M: Comparison of ribotyping, randomly amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing of Lactobacillus rhamnosus and L. casei strains. Appl Environ Microbiol 65: 3908-3914, 1999.
39. Lewis SJ, Burmeister S: A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. Eur J Clin Nutr 59: 776-780, 2005.
40. Larsen CN, Nielsen S, Kaestel P, Brockmann E, Bennedsen M, Christensen HR, Eskesen DC, Jacobsen BL, Michaelsen KF: Doseresponse study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 60: 1284-1293, 2006.
41. Simons LA, Amansec SG, Conway P: Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis 16: 531-535, 2006.
42. Greany KA, Bonorden MJL, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, Feirtag J, Thomas W, Kurzer MS: Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 62: 232-237, 2008.
43. Lassig A, Karjalainen H, Saxelin M, Surakka A, Tynkkynen S, Vapaatalo H, Korpela R, Hatakka K: Oral and intestinal survival of probiotics given in different food matrixes. A poster presented at SSA GutImpact: 3rd Platform Meeting on Foods for Intestinal Health, 29-31 August 2007, Haikko, Finland.